slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 60,421-60,450
Pages 2,605
Rows per page 30
Component
60,421-60,450 of 78,138
33
The chart highlights the efficacy of CBD in reducing anxiety during the 'A' (Anticipation) and 'S' (Speaking) phases of the challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
34
The chart highlights a statistically significant difference between CBD and Placebo groups during the speaking phase.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
35
The chart highlights the performance phase where the PH94B group shows a downward trend in distress compared to the placebo group.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
37
The chart highlights the 'Speech' phase with a box. SUDS is a standard clinical measure for anxiety.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
45
The right-hand diagram is a stylized funnel/segmentation representation of the addressable market.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
46
The slide uses a pharmacokinetic line chart to demonstrate rapid absorption and a bulleted list to summarize clinical efficacy in GAD and panic models.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
50
The slide uses a process flow diagram to illustrate the clinical trial methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
56
The chart displays a steady growth trajectory for the drug's revenue.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
02
The slide uses stacked bar charts to compare AUM vs Base Fees for four different business segments.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Business Model1 hit
07
The slide presents experimental data from a study on live-attenuated pneumococcal vaccines.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
The slide uses bioluminescence imaging to visualize bacterial load in the ear region of mice.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
The data shows ELISA absorbance results comparing vehicle (PBS) to the vaccine construct (LAV-D-M1) across four different pathogen serotypes/species.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
05
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
02
The chart is a dot plot comparing baseline ALSFRS-R scores across various clinical trials, highlighting NurOwn's lower baseline.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The chart displays the first principal component for each pathway over 20 weeks, comparing NurOwn and Placebo groups.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
17
The slide defines MACC and explains how to interpret the x-axis (reduction potential) and y-axis (cost).Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
19
The slide uses a waterfall-style MACC chart connected to a stacked bar chart showing the percentage distribution of initiatives by maturity level.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
21
The slide highlights a third-party business model for cogeneration.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
31
The slide uses a combination of a bar chart for quantitative data and icons with text for qualitative strategic goals.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Evidence1 hit
32
The slide uses a waterfall chart to show the buildup of production capacity (KT) by 2025e across different entities.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Evidence1 hit
37
The slide uses a three-column layout to explain the concept, show growth in LCA usage, and provide a comparative case study.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Evidence1 hit
52
The slide uses a waterfall-style growth chart to show the path from 200kt to 1,000kt capacity.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Resolution1 hit
09
The slide highlights a 51% growth in average total AUM since the closing of the acquisition.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
10
The slide uses a donut chart to visualize the split between sold and retained loan participations.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
16
The slide uses a timeline-based flow to illustrate the net change in banking centers through acquisitions, de novo openings, and closures/sales.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank 1 hit
27
Includes non-GAAP measures for NIM and Loan Yield; data as of June 30, 2022.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · Financials1 hit
30
Data as of June 30, 2022. Values in millions.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · Financials1 hit
32
The slide provides a granular view of loan types including Commercial, OOCRE, NOOCRE, Construction & Land, and 1-4 Family, with specific metrics for outstanding, unfunded, average loan size, and NPL percentages.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Mece Breakdown1 hit
35
The slide uses a donut chart to visualize the concentration of specific sectors versus a large 'All Others' category, supported by a detailed data table.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Mece Breakdown1 hit